RxDoctor Payments Data

Timothy Wagner, DO

Family Medicine · Amherst, OHNPI 1205949690

Payments from drug & device makers

$9,154in general payments, 2019–2025

Across 601 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$880
  • Lilly USA, LLC$763
  • GSK$715
  • Novo Nordisk$697
  • Pfizer$590
  • Astellas Pharma US Inc$442
  • plus $5K from 46 others

What the payments were for

  • Food & beverage$8,92998%
  • Education$2252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,154 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$93,816
Medicare patients
281
Services billed
5,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin223$267,799
OzempicSemaglutide131$214,109
TrulicityDulaglutide164$187,849
MounjaroTirzepatide145$187,163
EliquisApixaban132$147,949
Trelegy ElliptaFluticasone/Umeclidin/Vilanter187$146,089
FarxigaDapagliflozin Propanediol130$123,543
RybelsusSemaglutide55$93,788
XareltoRivaroxaban53$44,356
XifaxanRifaximin12$44,041
EntrestoSacubitril/Valsartan24$30,023
JanuviaSitagliptin Phosphate27$28,515
RexultiBrexpiprazole16$23,651
KerendiaFinerenone25$21,065
MyrbetriqMirabegron30$14,504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$763$375,011309 claims
Novo NordiskOzempic, Rybelsus$697$307,897186 claims
Boehringer IngelheimJardiance, Spiriva Respimat$238$280,072241 claims
GSKTrelegy Ellipta, Breo Ellipta$715$160,203221 claims
PfizerEliquis$590$147,949132 claims
AstraZenecaFarxiga, Symbicort$437$134,103166 claims
Johnson & JohnsonXarelto, Invokana$246$56,04371 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$276$53,32629 claims
NovartisEntresto$203$30,02324 claims
MerckJanuvia$327$28,51527 claims
Otsuka America Pharmaceutical, Inc.Rexulti$260$23,65116 claims
BayerKerendia$230$21,06525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Amherst

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →